Tokyo, June 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061836) titled 'Evaluation of the Utility of Urinary PGE-MUM in Inflammatory Bowel Disease: A Multicenter Prospective Study' on June 15.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University
Condition:
Condition - Ulcerative colitis, Crohn's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the utility of urinary PGE-MUM as a biomarker for disease activity and prediction of therapeutic outcomes in patients with ulcerative colitis and Crohn's disease.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients with inflammatory bowel disease who are receiving outpatient or inpatient care at Okayama University Hospital or participating research institutions
Key exclusion criteria - 1.Patients without a confirmed diagnosis
2.Patients with ulcerative colitis who have undergone total colectomy
3.Patients with active malignancy
4.Pregnant or breastfeeding patients
5.Patients who have not provided consent to participate in this study
6.Patients deemed unsuitable for participation by the principal investigator
Target Size - 180
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 03 Month 25 Day
Date of IRB - 2025 Year 03 Month 25 Day
Anticipated trial start date - 2025 Year 05 Month 01 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070584
Disclaimer: Curated by HT Syndication.
